MedTrace Logo

The Study of Intradialytic Symptoms in Subjects Treated With Qd 500vs Qd 300

NCT05947708 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 41

Last updated 2023-07-17

No results posted yet for this study

Summary

Study Goal is to determine the impact of dialysate flow rate (Qd) on Subject reported dialysis related symptoms and on time to recovery post dialysis.

Conditions

  • End Stage Renal Disease on Dialysis

Interventions

DEVICE

Dialysate Flow Rate

Hemodialysis is completed with dialysate being used at differing flow rates. Flow rates will be modified to see if this is a causal factor in post-dialysis recovery.

Sponsors & Collaborators

  • White Plains Hospital

    collaborator OTHER

  • Outset Medical

    lead INDUSTRY

Principal Investigators

  • Christopher Gunter · Outset Medical

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-15
Primary Completion
2019-10-15
Completion
2020-01-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05947708 on ClinicalTrials.gov